Table 2.
MNTE performance indicators in the 12 countries that have not achieved MNTE
|
TTCV2+ coverage from the WHO/UNICEF Joint Reporting Form6 |
MNTE indicators from most recent DHS7or MICS8 |
|||||||
|---|---|---|---|---|---|---|---|---|
| TTCV2+ coverage in 2019 | TTCV2+ coverage during the year of most recent DHS or MICS | Year of most recent DHS or MICS | TTCV2+ | PAB | Health facility delivery | SBA | ANC1 | |
| Afghanistan | 85% | 93% | 2015 | 34% | 53% | 48% | 51% | 59% |
| Angola | 54% | 70% | 2016 | 56% | 66% | 46% | 50% | 82% |
| Central African Republic | 86% | 76% | 2010 | ND | ND | 53% | ND | 68% |
| Guinea | 94% | 91% | 2018 | 48% | 59% | 53% | 55% | 81% |
| Mali | 72% | 75% | 2018 | 36% | 50% | 67% | 67% | 80% |
| Nigeria | 40% | 50% | 2018 | 53% | 62% | 39% | 43% | 67% |
| Pakistan | 62% | 60% | 2018 | 57% | 64% | 62% | 64% | 80% |
| Papua New Guinea | 31% | 25% | 2018 | 27% | 38% | 55% | 55% | 76% |
| Somalia | 58% | 58% | 2020 | 17% | 27% | 21% | 32% | 31% |
| South Sudan | 38% | 46% | 2010 | 28% | 37% | 12% | 19% | 62% |
| Sudan | 53% | 53% | 2014 | 32% | 58% | 28% | 78% | 79% |
| Yemen | 25% | 18% | 2013 | 9% | 28% | 30% | 45% | 60% |
ANC1=first antenatal care visit. DHS=Demographic Health Survey. MICS=Multiple Indicator Cluster Survey. MNTE=maternal and neonatal tetanus elimination. ND=no data available. PAB=protection at birth. SBA=skilled birth attendance. TTCV2+=at least two doses of tetanus toxoid-containing vaccine.